Cited by 149Advanced Glycation End Products researchChronic Kidney Disease and DiabetesAdipokines, Inflammation, and Metabolic Diseases

The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.

Positive association between serum levels of advanced glycation end products and the soluble form of receptor for advanced glycation end products in nondiabetic subjects

Yamagishi, Sho-ichi, Adachi, Hisashi, Nakamura, Kazuo, Matsui, Takanori, Jinnouchi, Yuko, Takenaka, Katsuhiko, Takeuchi, Masayoshi, Enomoto, Mika, Furuki, Kumiko, Hino, Asuka, Shigeto, Yoshiyuki, Imaizumi, Tsutomu·2006·Metabolism

DOI 10.1016/j.metabol.2006.05.007

Open this paper in CoChat — free account

Abstract

The advanced glycation end products (AGEs)-receptor for AGE (RAGE) axis is implicated in diabetic vascular complications. Administration of soluble form of RAGE (sRAGE) to mice has been shown to block the AGE-elicited tissue damage by acting as a decoy. These observations suggest that endogenous sRAGE may capture and eliminate circulating AGEs and decrease its serum levels. However, because AGEs up-regulate tissue RAGE expression and endogenous sRAGE could be generated from the cleavage of cell surface RAGE, sRAGE may be positively, rather than inversely, associated with circulating AGEs by reflecting tissue RAGE expression. In this study, we investigated the association of sRAGE with serum levels of AGEs in humans. Data for fasting serum sRAGE and AGE levels of 184 nondiabetic subjects were obtained from a general population in Japan. We also measured body mass index (BMI), waist circumference, blood pressure, and blood biochemistries in this population. Uni- and multivariate analyses were applied for the determinants of serum sRAGE levels. The average sRAGE levels were 0.40 +/- 0.17 ng/mL in males and 0.43 +/- 0.14 ng/mL in females, respectively. In the univariate analysis, BMI (P < .05, inversely), waist circumference (P < .05, inversely), AGEs (P < .05), and alcohol intake (P < .05, inversely) were significantly associated with sRAGE levels. After performing multivariate analyses, BMI (P < .05, inversely) and AGEs (P < .05) still remained significant independently. The present study is the first demonstration that serum sRAGE levels were positively associated with circulating AGEs in the nondiabetic general population. Endogenous sRAGE levels are elevated in parallel with serum AGE levels.

Integrity signals

Registry

Crossref · 10.1016/j.metabol.2006.05.007

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement
Grundy, S. M., Cleeman, J. I., Daniels, S. R., Donato, K. A., Eckel, R. H., Franklin, B. A., Gordon, D. J., Krauss, R. M., Savage, P. J., Smith, S. C., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.169404 · Cited by 11,961
Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement Executive Summary
Grundy, S. M., Cleeman, J. I., Daniels, S. R., Donato, K. A., Eckel, R. H., Franklin, B. A., Gordon, D. J., Krauss, R. M., Savage, P. J., Smith, S. C., et al. (2005) · Cardiology in Review · doi:10.1097/01.crd.0000380842.14048.7e · Cited by 1,600
Advanced protein glycosylation in diabetes and aging
Brownlee, M. D. (1995) · Annual Review of Medicine · doi:10.1146/annurev.med.46.1.223 · Cited by 1,312
Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts
Park, L., Raman, K. G., Lee, K. J., Lu, Y., Ferran, L. J., Chow, W. S., Stern, D. M., & Schmidt, A. M. (1998) · Nature Medicine · doi:10.1038/2012 · Cited by 1,103
Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging.
Vlassara, H., Bucala, R., & Striker, L. J. (1994) · PubMed · Cited by 848
Activation of the Receptor for Advanced Glycation End Products Triggers a p21 -dependent Mitogen-activated Protein Kinase Pathway Regulated by Oxidant Stress
Lander, H. M., Tauras, J. M., Ogiste, J. S., Hori, O., Moss, R. A., & Schmidt, A. M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.28.17810 · Cited by 813
Activation of Receptor for Advanced Glycation End Products
Schmidt, A. M., Yan, S. D., Wautier, J., & Stern, D. M. (1999) · Circulation Research · doi:10.1161/01.res.84.5.489 · Cited by 799
Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury
YONEKURA, H., YAMAMOTO, Y., SAKURAI, S., PETROVA, R. G., ABEDIN, M. J., LI, H., YASUI, K., TAKEUCHI, M., MAKITA, Z., TAKASAWA, S., et al. (2003) · Biochemical Journal · doi:10.1042/bj20021371 · Cited by 716
Self-citation
Renal Insufficiency and Heart Failure
McAlister, F. A., Ezekowitz, J. A., Tonelli, M. A., & Armstrong, P. W. (2004) · Circulation · doi:10.1161/01.cir.0000116764.53225.a9 · Cited by 702
RAGE Blockade Stabilizes Established Atherosclerosis in Diabetic Apolipoprotein E–Null Mice
Bucciarelli, L. G., Wendt, T., Qu, W., Lu, Y., Lalla, E., Rong, L., Goova, M. T., Moser, B., Kislinger, T., Lee, D. C., et al. (2002) · Circulation · doi:10.1161/01.cir.0000039325.03698.36 · Cited by 562

Flagged first, then by citations

Show all 33 references

Sorted by citations

Items 101–149 of 149

Higher serum soluble receptor for advanced glycation end product levels and lower prevalence of metabolic syndrome among Japanese adult men: a cross-sectional study
Momma, H., Niu, K., Kobayashi, Y., Huang, C. X., Chujo, M., Otomo, A., Tadaura, H., Miyata, T., & Nagatomi, R. (2014) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-6-33 · Cited by 18
Pathological Role of Advanced Glycation End Products (AGEs) and their Receptor Axis in Atrial Fibrillation
Yamagishi, S., Sotokawauchi, A., & Matsui, T. (2019) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557519666190311140737 · Cited by 17
Self-citation
Advanced glycation end products and insulin resistance in diabetic nephropathy
Parwani, K., & Mandal, P. (2024) · Vitamins and hormones · doi:10.1016/bs.vh.2024.02.007 · Cited by 19
Serum soluble receptor of advanced glycation end products and risk of metabolic syndrome in Egyptian obese women
Zaki, M. E., Kamal, S., Kholoussi, S., El-Bassyouni, H. T., Yousef, W., Reyad, H., Mohamed, R., & Basha, W. A. (2017) · EXCLI journal · doi:10.17179/excli2017-275 · Cited by 16
Evaluation of the AGE/sRAGE Axis in Patients with Multiple Myeloma
Allegra, A., Musolino, C., Pace, E., Innao, V., Salvo, E. D., Ferraro, M., Casciaro, M., Spatari, G., Tartarisco, G., Allegra, A. G., et al. (2019) · Antioxidants · doi:10.3390/antiox8030055 · Cited by 16
Plasma Levels of Free NƐ-Carboxymethyllysine (CML) after Different Oral Doses of CML in Rats and after the Intake of Different Breakfasts in Humans: Postprandial Plasma Level of sRAGE in Humans
Helou, C., Lima, M. T. N. S., Niquet‐Léridon, C., Jacolot, P., Boulanger, É., Delguste, F., Guilbaud, A., Génin, M., Anton, P. M., Delayre‐Orthez, C., et al. (2022) · Nutrients · doi:10.3390/nu14091890 · Cited by 15
Circulating soluble advanced glycation end product is inversely associated with the significant risk of developing cancer: evidence from a meta-analysis
He, L., Bao, H., Xue, J., Zheng, L., Zhang, Q., Sun, L., & Pan, H. (2014) · Tumor Biology · doi:10.1007/s13277-014-2122-7 · Cited by 15
Higher hepatic advanced glycation end products and liver damage markers are associated with nonalcoholic steatohepatitis
Figueroa, K. P., Tapia, G., Cadagan, C., Quezada, N., Torres, J., D’Espessailles, A., & Pettinelli, P. (2022) · Nutrition Research · doi:10.1016/j.nutres.2022.04.005 · Cited by 16
Effectiveness of Early Advanced Glycation End Product Accumulation Testing in the Diagnosis of Diabetes: A Health Risk Factor Analysis Using the Body Mass Index as a Moderator
Zhang, Y., Jiang, T., Liu, C., Hu, H., Dai, F., Li, X., & Zhang, Q. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.766778 · Cited by 14
Receptor for advanced glycation end products (RAGE): Novel biomarker and therapeutic target for atrial fibrillation
Zhang, Q., Li, G., & Liu, T. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.07.038 · Cited by 13
The Value of Circulating Biomarkers in Bicuspid Aortic Valve-Associated Aortopathy
Naito, S., Hillebrand, M., Bernhardt, A. M. J., Jagodzinski, A., Conradi, L., Detter, C., Sydow, K., Reichenspurner, H. C., Kodolitsch, Y. V., & Girdauskas, E. (2016) · The Thoracic and Cardiovascular Surgeon · doi:10.1055/s-0036-1583525 · Cited by 12
Advanced glycation end products and soluble receptor as markers of oxidative stress in children on hemodialysis
El-Saeed, G. S. M., Fadel, F. I., Elshamaa, M. F., Galal, R. E. E., Elghoroury, E. A., Nasr, S. A., Thabet, E. H., & Abdelrahman, S. (2015) · Renal Failure · doi:10.3109/0886022x.2015.1077317 · Cited by 12
Effect of the consumption of yacon flour and energy-restricted diet on glycation markers, and association between these markers and factors linked to obesity in adults with excess body weight: A randomized, double-blind, placebo-controlled clinical trial
Ribeiro, P. V. D. M., Machado, A. M., da Silva, N. B. M., de Oliveira, L. L., & Alfenas, R. D. C. G. (2021) · Nutrition · doi:10.1016/j.nut.2021.111395 · Cited by 11
Circulating Soluble Receptor for Advanced Glycation End Products is Inversely Correlated to Oxidized Low-density Lipoproteins in Asymptomatic Subjects
Kotani, K., Caccavello, R. J., Taniguchi, N., & Gugliucci, A. (2012) · Journal of International Medical Research · doi:10.1177/030006051204000527 · Cited by 11
Low plasma levels of the soluble receptor for advanced glycation end products in HIV-infected patients with subclinical carotid atherosclerosis receiving combined antiretroviral therapy
Jeong, S. J., Kim, C. O., Song, Y. G., Baek, J. H., Kim, S. B., Jin, S. J., Ku, N. S., Han, S. H., Choi, J. Y., Lee, H. C., et al. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.08.003 · Cited by 11
Endogenous Secretory Receptor for Advanced Glycation End Products and Chronic Kidney Disease in the Elderly Population
Dalal, M., Semba, R. D., Sun, K., Crasto, C., Varadhan, R., Bandinelli, S., Fink, J. C., Guralnik, J. M., & Ferrucci, L. (2011) · American Journal of Nephrology · doi:10.1159/000324846 · Cited by 11
The role of vascular inflammation markers in deficiency of adenosine deaminase 2
Akça, Ü. K., Sağ, E., Ünal, Ş., Cüceoğlu, M. K., Bilginer, Y., & Özen, S. (2021) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2021.04.013 · Cited by 10
Low‐Density Lipoprotein Levels are One of the Independent Determinants of Circulating Levels of Advanced Glycation End Products in Nondiabetic Subjects
Yamagishi, S., Adachi, H., Matsui, T., Nakamura, K., Takeuchi, M., Enomoto, M., Fukami, A., Otsuka, M., Kumagae, S., Nanjo, Y., et al. (2009) · Clinical Cardiology · doi:10.1002/clc.20532 · Cited by 9
Self-citation
Elevated endogenous secretory receptor for advanced glycation end products (esRAGE) levels are associated with circulating soluble RAGE levels in diabetic children
Saito, R., Araki, S., Yamamoto, Y., & Kusuhara, K. (2017) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2016-0262 · Cited by 8
Relationship between serum levels of endogenous secretory RAGE and blood pressure in male nondiabetic patients with obstructive sleep apnea
Cai, W., Sun, J.-F., Liu, Y., Xu, J., Xiao, J.-R., Duan, X.-M., Liu, J.-Y., & Zhang, W. (2015) · Journal of Human Hypertension · doi:10.1038/jhh.2015.46 · Cited by 8
A One-Month Advanced Glycation End Products—Restricted Diet Improves CML, RAGE, Metabolic and Inflammatory Profile in Patients with End-Stage Renal Disease Undergoing Haemodialysis
Aroni, A., Detopoulou, P., Presvelos, D., Kostopoulou, E., Ioannidis, A., Panoutsopoulos, G. I., Zyga, S., Kosmidis, G., Spiliotis, B. E., & Gil, A. P. R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168893 · Cited by 7
AGE and RAGE inhibitors in the treatment of diabetic retinopathy
Bhatwadekar, A. D., & Stitt, A. W. (2007) · Expert Review of Ophthalmology · doi:10.1586/17469899.2.1.105 · Cited by 7
Can soluble receptor for advanced glycation end-product (sRAGE) levels in blood be used as a predictor of cardiovascular diseases?
Katakami, N. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.09.007 · Cited by 7
Advanced Glycation End Product (AGE) and Soluble Receptor of AGE (sRAGE) Levels in Relation to Periodontitis Severity and as Putative 3-Year Outcome Predictors in Patients Undergoing Coronary Artery Bypass Grafting (CABG)
Reichert, S., Hofmann, B., Kohnert, M., Santos, A. N., Friebe, L., Grollmitz, J., Schaller, H., & Schulz, S. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11144105 · Cited by 6
Vagus nerve electrical stimulation inhibits serum levels of S100A8 protein in septic shock rats
Lei, M., & LIU, X.-X. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5002 · Cited by 6
Soluble receptor for advanced glycation end products (sRAGE) and carotid intima-media thickness (CIMT) in type 1 diabetes Mellitus: Possible association with diabetic vascular complications
Sherif, E. M., Abdelmaksoud, A. A., Issa, H. M., & Mohamed, S. A. (2014) · Egyptian Journal of Medical Human Genetics · doi:10.1016/j.ejmhg.2014.06.003 · Cited by 5
Circulating Levels of the Soluble Receptor for AGE (sRAGE) during Escalating Oral Glucose Dosages and Corresponding Isoglycaemic i.v. Glucose Infusions in Individuals with and without Type 2 Diabetes
Fotheringham, A. K., Bagger, J. I., Borg, D. J., McCarthy, D. A., Holst, J. J., Vilsbøll, T., Knop, F. K., & Forbes, J. M. (2020) · Nutrients · doi:10.3390/nu12102928 · Cited by 6
Soluble receptor for advanced glycation end products in critically ill patients and its associations with other clinical markers and 28-day mortality
Cheng, Y., Zhong, J., Zhao, L., Xiang, Y., Zeng, F. J., & Cai, D.-H. (2014) · Clinical Interventions in Aging · doi:10.2147/cia.s71130 · Cited by 5
Cardiovascular Complications in Renal Failure: Implications of Advanced Glycation End Products and Their Receptor RAGE
Koyama, H., & Nishizawà, Y. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-857-7_13 · Cited by 4
AGE/RAGE as a Mediator of Insulin Resistance or Metabolic Syndrome: Another Aspect of Metabolic Memory?
Koyama, H., & Yamamoto, T. (2012) · InTech eBooks · doi:10.5772/20468 · Cited by 1
Participation of toxic AGEs (TAGE) in a variety of diseases
Takeuchi, M. (2012) · Folia Pharmacologica Japonica · doi:10.1254/fpj.139.193 · Cited by 2
Self-citation
A history of maternal separation drives systemic aging-associated signatures in middle-aged male rats
Chaudhari, P. R., Chaurasiya, A. H., Vaidya, A. D. B., Kulkarni, M. J., & Vaidya, V. A. (2026) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2026.1809602 · Cited by 1
sRAGE is associated with low waist circumference and Hb levels in NAFLD
Hyogo, H., Yamagishi, S., Maeda, S., Nakahara, T., Kimura, Y., & Chayama, K. (2013) · Open Medicine · doi:10.2478/s11536-013-0224-z · Cited by 1
Self-citation
A pathophysiologic evaluation of the receptor for advanced glycation end products (RAGE) in the lung
Englert, J. M. (2009) · D-Scholarship@Pitt (University of Pittsburgh) · Cited by 1
Confirmation de biomarqueurs pour le pronostic du sepsis et développement de tests rapides
Dubois, C. (2019) · theses.fr (ABES) · doi:10.70675/4101c43dzc2b3z4ae2zb315z16d8d8252081 · Cited by 1
VEGFR-1 function and dysfunction in monocytes
Tchaikovski, V. (2009) · Research Publications (Maastricht University) · doi:10.26481/dis.20091216vt
A randomised, double blind, crossover study of the effects of CLA isomers on inflammation, body composition, metabolic profiles and vascular function in subjects with the metabolic syndrome
Bolusani, H. (2013) · ORCA Online Research @Cardiff (Cardiff University)
Evaluation of the role of soluble receptors for advanced glycosylated end-products in polycystic ovarian syndrome
Sokkary, H. H. A. H. E., Sobhy, M. M., Elenein, W. M. A., & Mohamed, H. E. (2016) · Evidence Based Women s Health Journal · doi:10.1097/01.ebx.0000479689.77989.ee
Metabolic syndrome is inversely related to soluble receptor for advanced glycation end products: a study in mother-infant pairs
Klenovicsová, K., Boor, P., Hrachova, J., Furková, K., & Šebeková, K. (2011) · Biopolymers and Cell · doi:10.7124/bc.00008c
Sputum–plasma ratio of soluble receptor for advanced glycation end-products in patients with chronic obstructive pulmonary disease
Hassanein, E. G., Elganady, A. A., Baess, A. I., Issa, Y. A., & ElAkhtel, E. M. (2016) · Egyptian Journal of Chest Diseases and Tuberculosis · doi:10.1016/j.ejcdt.2016.04.002
Correlation of endogenous secretory receptor for advanced glycation end product (esRAGE) with metabolic health related biomarkers of skeletal muscle
Pajari, J. (2016) · Jyväskylä University Digital Archive (University of Jyväskylä)
Comparative Evaluation of Salivary-Soluble Receptor for Advanced Glycation End Product (sRAGE) Levels among Betel Chewers and Chronic Periodontitis Patients
Rajkumar, C., Vasanthi, V., Karthik, K. R., & Rajkumar, K. (2021) · Biomedical and Biotechnology Research Journal (BBRJ) · doi:10.4103/bbrj.bbrj_112_21
A Review on Invitro Evolution of Glimepiride Tablets
-, M. S. D., & -, V. B. W. (2023) · International Journal For Multidisciplinary Research · doi:10.36948/ijfmr.2023.v05i03.2845
RECEPTOR FOR ADVANCED GLYCATION END-PRODUCTS: EXPRESSION AND SIGNALING
Gefter, J. V. (2009) · D-Scholarship@Pitt (University of Pittsburgh)
Effects of early-life and chronic exposure to dietary advanced glycation end-products on chronic low-grade inflammation and age-associated disorders
Lima, M. T. N. S. (2023) · theses.fr (ABES) · doi:10.70675/aaf90876z1a0cz4bdbzb765zd592559927f8
RAGE Signalling in Acute Inflammatory Disorders: Therapeutic Potential of Natural Products
Wang, Q., Luo, W., Wan, Q., Li, Y., Latawiec, D., Sutton, R., Windsor, J. A., Huang, W., Szatmary, P., & Liu, T. (2026) · Biomolecules · doi:10.3390/biom16070929
Dietary and Circulating Advanced Glycation End Products in Relation to Inflammation and Cognitive Function in Healthy Young Adults
Çil, M. A., Karataş, N., Ozgeris, F. B., Taşğın, E., Sarı, S., & Özkalaycı, R. E. (2026) · Nutrients · doi:10.3390/nu18203442
BindingDB Entry 50000408: Targeting the Receptor for Advanced Glycation Endproducts (RAGE): A Medicinal Chemistry Perspective.
BindingDB (2019) · UC San Diego · doi:10.7270/q2kd21bp
Advanced glycation and type 1 diabetes
Nin, J. W. M. (2012) · Research Publications (Maastricht University) · doi:10.26481/dis.20120607jn

Authors: Yamagishi, S.-I., Adachi, H., Nakamura, K., Matsui, T., Jinnouchi, Y., Takenaka, K., Takeuchi, M., Enomoto, M., Furuki, K., Hino, A., Shigeto, Y., & Imaizumi, T.
Affiliations: Kurume University (JP)
Hokuriku University (JP)
Corresponding author: Yamagishi, Sho-ichi
ORCID: Yamagishi, Sho-ichi
Adachi, Hisashi
Matsui, Takanori
Takeuchi, Masayoshi
Enomoto, Mika
Venue: Metabolism
Publisher: Elsevier BV
Published: 2006-09
Volume: 55
Issue: 9
Pages: 1227-1231
ISSN: 0026-0495 (ISSN-L)
DOI: 10.1016/j.metabol.2006.05.007
OpenAlex: W2042667331
Cited by: 148
References: 33
Citations by year: 2026: 3 · 2024: 2 · 2023: 3 · 2022: 7 · 2021: 5 · 2020: 7 · 2019: 7 · 2018: 1 · 2017: 5 · 2016: 13 · 2015: 7 · 2014: 11 · 2013: 7 · 2012: 9
FWCI: 9.80
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
Locations: Metabolism (publishedVersion)
PubMed (publishedVersion)
Funders: Ministry of Education, Culture, Sports, Science and Technology
Kimura Memorial Heart Foundation
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
Keywords: advanced glycation end products, soluble receptor for advanced glycation end products, non-diabetic patients, body mass index, waist circumference, alcohol consumption, diabetic vascular complications, AGE-RAGE axis
MeSH terms: Receptor for Advanced Glycation End Products, Aged, Alcohol Drinking, Analysis of Variance, Blood Chemical Analysis, Blood Pressure, Female, Humans, Japan, Male, Middle Aged, Receptors, Immunologic, Solubility, Body Mass Index, Glycation End Products, Advanced, Body Size

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Positive association between serum levels of advanced glycation end products and the soluble form of receptor for advanced glycation end products in nondiabetic subjects

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks